108Indexed trials
Market Rank #29 · Evidence Tier A
Hungary
Neuroscience Intelligence
Hungary neuroscience intelligence: 108 indexed trials, 31 institutions, research score 34.53.
24Recruiting
31Research institutions
34.5Research score
Evidence profile
60Sponsors
17Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 34.5 · Data confidence 100.00 · Evidence 34.5
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons30trials
epilepsy24trials
alzheimers9trials
multiple_sclerosis8trials
schizophrenia7trials
autism6trials
depression4trials
stroke3trials
other_neurology3trials
neuromuscular3trials
Leading indexed sponsors
Merck Sharp & Dohme LLC15trials
Hoffmann-La Roche8trials
Boehringer Ingelheim5trials
UCB Pharma4trials
GlaxoSmithKline3trials
H. Lundbeck A/S3trials
UCB Biopharma S.P.R.L.3trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
Eisai Limited3trials
Eisai Inc.2trials